A Phase I/II Study to Evaluate Safety and Efficacy of the Boron Neutron Capture Therapy (BNCT) Using B10 L-BPA as Boron Carrier in Malignant Brain Tumors.
Latest Information Update: 11 Jun 2025
At a glance
- Drugs B10 L BPA (Primary)
- Indications Brain cancer
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 11 Jun 2025 New trial record